Using the GEPIA2 database, we found that STAT5a mRNA expression has significantly lower expression in breast, lung, and ovarian cancers, whereas STAT5a mRNA has significant overexpression in lymphoid neoplasm diffuse large B-cell lymphoma, glioblastoma, and glioma compared with normal tissue (Figure 2). The gene discussed is STAT5A; the disease is ovarian carcinoma.